17 August 2022
Latham & Watkins Advises on Halozyme Therapeutics, Inc.’s Upsized Private Offering of $625 Million of Convertible Senior Notes
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Cheston Larson Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Michael Sullivan Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Peter Simon | Latham & Watkins LLP | Associate | corporate | Not stated |
| Rachel Staub | Latham & Watkins LLP | Associate | corporate | Not stated |
| Alex Stuart-Lovell | Latham & Watkins LLP | Associate | corporate | Not stated |
| Greg Rodgers | Latham & Watkins LLP | Partner | convertible debt | New York |
| Andrew Blumenthal | Latham & Watkins LLP | Associate | convertible debt | Not stated |
| Andrew Bentz | Latham & Watkins LLP | Associate | convertible debt | Not stated |
| Ben Haas | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Steven Chinowsky | Latham & Watkins LLP | Partner | intellectual property | San Diego |
| Darryl Steensma | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Robert Yeh | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Reza Mojtabaee-Zamani | Latham & Watkins LLP | Partner | derivatives | New York |
| Jack Neff | Latham & Watkins LLP | Associate | derivatives | Not stated |
| Hera Liao | Latham & Watkins LLP | Associate | derivatives | Not stated |
| Bora Bozkurt | Latham & Watkins LLP | Partner | tax | New York |
| Ted Gkoo | Latham & Watkins LLP | Associate | tax | Not stated |
16 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 625m ($625.0 million)
- What the figure measures
- Issue size
- Client
- Halozyme Therapeutics, Inc.Issuer
- Counterparties
- initial purchasers (Underwriters)